Retatrutide — Three Metabolic Signals in One Molecule
Retatrutide is being studied for appetite, body weight, blood sugar and how the body uses energy. What makes it different is simple: one molecule activates three hormone receptors — GLP-1, GIP and glucagon. It has reached Phase 3 trials, but it is still investigational and is not an approved medicine. Published batch documentation is shown on the COA page when a matching record is available.
Why review Retatrutide with Aeternum Life
The listing identifies this item as a laboratory research material.
Identity, format, storage, and package information are shown on the product page.
Destination availability, dispatch details, and tracking are confirmed for the order.
COA records appear by product and batch when a matching record is published.
What is Retatrutide?
Retatrutide is a synthetic peptide designed to activate three hormone receptors: GLP-1, GIP and glucagon. Semaglutide uses one of these signals, tirzepatide uses two, and retatrutide combines all three.
Researchers are studying how that three-part signal relates to appetite, blood sugar, body weight and energy use. Retatrutide is now in Phase 3 trials, but it is still investigational and is not an approved medicine. Aeternum Life supplies batch-tested research material with a matching Certificate of Analysis.
Research directions
Retatrutide research asks what changes when three metabolic hormone signals are combined in one molecule.
One molecule activates GLP-1, GIP and glucagon receptors—the defining feature of retatrutide.
Clinical trials study how the combined signals relate to hunger, fullness and how much people eat.
Phase 3 studies are measuring body-weight change and related health outcomes in defined patient groups.
GLP-1 and GIP are linked to how the body responds to food and manages blood sugar.
The added glucagon signal lets researchers examine energy expenditure alongside appetite.
Because it is investigational, ongoing trials also need to define side effects, longer-term safety and who may or may not benefit.
For research purposes only. These materials are not drugs or dietary supplements and are not intended to diagnose, treat, cure or prevent any disease.
Retatrutide documentation
- Published product specification
- Reported purity and test date when available
- Batch number shown on matching records
- Laboratory and verification details only when supplied
The COA page shows the batch documentation currently published. Missing fields are left blank rather than inferred.
Join the Aeternum Life community
Get new research summaries, batch updates, restock alerts and customer support. We do not provide dosing, reconstitution or administration guidance.
Join our TelegramHandling & Storage
Guidance for handling Retatrutide as a laboratory research material.
Store lyophilized Retatrutide cold and protected from light, sealed and dry until use.
Handle Retatrutide according to standard laboratory practice for research materials.
Published batch documentation is linked when a matching record is available.
Retatrutide is supplied strictly for laboratory and research use. Not for human or veterinary consumption; no administration or dosing guidance is provided.
Specifications
- Name
- Retatrutide (research code LY3437943)
- Class
- GLP-1 / GIP / glucagon triple agonist
- Appearance
- White lyophilized powder
- Size
- 10 mg per vial
- Purity
- ≥ 99% (HPLC, see COA)
- Storage
- Store at 2–8°C, protect from light
For research use. Not intended to diagnose, treat, cure or prevent any disease.
Frequently asked questions
What is Retatrutide studied for?
It’s studied in metabolic research around the GLP-1, GIP and glucagon pathways — appetite, blood sugar, energy use and body weight. It’s an investigational compound; we share these as research directions, not medical claims.
How is it different from semaglutide and tirzepatide?
Semaglutide activates GLP-1, tirzepatide activates GLP-1 and GIP, and retatrutide adds glucagon as a third signal. Retatrutide is still investigational. We do not provide dosing, reconstitution or administration guidance.
Is Retatrutide for human use?
No. Aeternum Life supplies Retatrutide strictly as a research-grade material for laboratory research. It is not sold for human or veterinary consumption.
Is a COA available for Retatrutide?
Published COA records are available by product and batch when a matching record exists. Laboratory and verification details appear only when stated in that record.
About Aeternum Life
Aeternum Life Limited publishes clearly labeled laboratory research materials and accessories, with specifications and available batch documentation.
Keep up with the Retatrutide research
New reviews, data and study summaries — sent when there is something worth reading, not on a schedule.
No spam. Unsubscribe anytime.
Questions before you order?
Message us on WhatsApp for product documentation, stock, shipping and order support — a real person, usually within a few hours.
Message us on WhatsAppExplore the full Aeternum Life range
Retatrutide is part of the Aeternum Life research catalog. Review its intended-use status, specifications, and any currently published batch record before ordering.
Browse all products